1. Home
  2. OXBR vs CNSP Comparison

OXBR vs CNSP Comparison

Compare OXBR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

HOLD

Current Price

$0.97

Market Cap

8.0M

Sector

Finance

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$4.28

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXBR
CNSP
Founded
2013
2017
Country
Cayman Islands
United States
Employees
4
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
7.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OXBR
CNSP
Price
$0.97
$4.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$20.00
AVG Volume (30 Days)
49.4K
27.0K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.03
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$80.09
N/A
Revenue Next Year
$85.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.74
52 Week High
$2.85
$10.59

Technical Indicators

Market Signals
Indicator
OXBR
CNSP
Relative Strength Index (RSI) 53.12 45.50
Support Level $0.93 $4.50
Resistance Level $1.42 $5.61
Average True Range (ATR) 0.12 0.30
MACD 0.01 -0.09
Stochastic Oscillator 63.64 11.59

Price Performance

Historical Comparison
OXBR
CNSP

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: